SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution

Area of Science:

• Immunology
• Virology
• Biotechnology

Background:

• Understanding humoral immunity to SARS-CoV-2 is crucial for diagnostics and vaccines.
• Antibody profiling at amino acid resolution provides detailed insights into host immune responses.

Purpose of the Study:

• To develop and validate a SARS-CoV-2 proteome peptide microarray for comprehensive antibody profiling.
• To map B-cell epitopes for IgM and IgG antibodies in early COVID-19 patients.
• To identify potential targets for diagnostic and therapeutic interventions.

Main Methods:

• Development of a SARS-CoV-2 proteome peptide microarray.
• Analysis of antibody interactions with viral proteins at amino acid resolution.
• Utilizing array data and structural analysis for epitope prediction.

Main Results:

• Demonstrated cross-reactivity of SARS-CoV-1 antibodies with SARS-CoV-2 nucleocapsid phosphoprotein.
• Constructed the first landscape of B-cell epitopes for SARS-CoV-2 IgM and IgG antibodies in early COVID-19 patients.
• Predicted a peptide epitope within the spike receptor-binding domain for neutralizing antibodies.

Conclusions:

• The SARS-CoV-2 proteome peptide microarray is a valuable platform for studying antibody responses in COVID-19 patients and animal models.
• The identified epitopes provide potential targets for developing diagnostics and therapeutics.
• This approach facilitates a deeper understanding of SARS-CoV-2 immunity.